AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇬🇭
Glimepiride/Metformin in Ghana
4 products registered with FDA Ghana — 4 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| SHALGLI-M 1-500 XR TABLETS (Each extended-release tablet contains Glimepiride/Metformin - 1mg/500mg) | UNKNOWN-64598faf | — | active | 1 Apr 2029 |
| SHALGLI-M 2-500 XR TABLETS (Each extended-release tablet contains Glimepiride/Metformin - 2mg/500mg) | UNKNOWN-bf456223 | — | active | 1 Apr 2029 |
| SHALGLI-M 1-500 XR TABLETS (Each extended-release tablet contains Glimepiride/Metformin - 1mg/500mg) | UNKNOWN-62260032 | — | active | 1 Apr 2029 |
| SHALGLI-M 2-500 XR TABLETS (Each extended-release tablet contains Glimepiride/Metformin - 2mg/500mg) | UNKNOWN-00c49dd6 | — | active | 1 Apr 2029 |
Glimepiride/Metformin — FDA Ghana Registration Details
FDA Ghana (Ghana) has 4 registered products containing Glimepiride/Metformin, of which 4 are currently active. Data is sourced directly from the official FDA Ghana drug register and refreshed daily.
Track Glimepiride/Metformin registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.